- BGN21.50m
- BGN28.45m
- BGN11.20m
Annual income statement for Etropal AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6.73 | 7.67 | 11.7 | 6.75 | 11.2 |
Cost of Revenue | |||||
Gross Profit | 2.89 | 3.19 | 4.49 | 4.11 | 4.96 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6.43 | 7.57 | 15.1 | 7.26 | 11 |
Operating Profit | 0.292 | 0.105 | -3.41 | -0.511 | 0.196 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.008 | 0.025 | -3.46 | -0.783 | -0.13 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.009 | 0.026 | -3.41 | -0.81 | -0.123 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 0.009 | 0.024 | -3.44 | -0.718 | -0.028 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.009 | 0.024 | -3.44 | -0.718 | -0.028 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.005 | 0.02 | -0.246 | 0.059 | 0.176 |
Dividends per Share |